Open Access
Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trial
Vincent I. Lau, Robert Fowler, Ruxandra Pinto, Alain Tremblay, Sergio Borgia, François M. Carrier, Matthew P. Cheng, John Conly, Cecilia T. Costiniuk, Peter Daley, Erick Duan, Madeleine Durand, Patricia S. Fontela, George Farjou, Mike Fralick, Anna Geagea, Jennifer Grant, Yoav Keynan, Kosar Khwaja, Nelson Lee, Todd C. Lee, Rachel Lim, Conar R. O’Neil, Jesse Papenburg, Makeda Semret, Michael Silverman, Wendy Sligl, Ranjani Somayaji, Darrell H.S. Tan, Jennifer L.Y. Tsang, Jason Weatherald, Cedric Philippe Yansouni, Ryan Zarychanski and Srinivas Murthy; for the E-CATCO authors, AMMI Clinical Research Network and Canadian Critical Care Trials Group
September 06, 2022 10 (3) E807-E817; DOI: https://doi.org/10.9778/cmajo.20220077
